150 related articles for article (PubMed ID: 33128509)
1. COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment.
Ramaswamy A; Nayak L; Roy Moulik N; Sengar M; Chinnaswamy G; Jobanputra K; Shah MJ; Kapoor A; Joshi A; Kumar A; Gokarn A; Bonda A; Cheriyalinkal Parambil B; Prasad M; Bagal B; Dhamne C; Narula G; Jain H; Ghosh J; Thorat J; Bajpai J; Menon N; Khattry N; Bhargava P; Punatar S; Gulia S; Banavali S; Gupta S; Srinivas S; Rath S; Vora T; Noronha V; Patil VM; Ostwal V; Prabhash K
Cancer Med; 2020 Dec; 9(23):8747-8753. PubMed ID: 33128509
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
3. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.
Hartman HE; Sun Y; Devasia TP; Chase EC; Jairath NK; Dess RT; Jackson WC; Morris E; Li P; Hochstedler KA; Abbott MR; Kidwell KM; Walter V; Wang M; Wang X; Zaorsky NG; Schipper MJ; Spratt DE
JAMA Oncol; 2020 Dec; 6(12):1881-1889. PubMed ID: 33119036
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Kuderer NM; Choueiri TK; Shah DP; Shyr Y; Rubinstein SM; Rivera DR; Shete S; Hsu CY; Desai A; de Lima Lopes G; Grivas P; Painter CA; Peters S; Thompson MA; Bakouny Z; Batist G; Bekaii-Saab T; Bilen MA; Bouganim N; Larroya MB; Castellano D; Del Prete SA; Doroshow DB; Egan PC; Elkrief A; Farmakiotis D; Flora D; Galsky MD; Glover MJ; Griffiths EA; Gulati AP; Gupta S; Hafez N; Halfdanarson TR; Hawley JE; Hsu E; Kasi A; Khaki AR; Lemmon CA; Lewis C; Logan B; Masters T; McKay RR; Mesa RA; Morgans AK; Mulcahy MF; Panagiotou OA; Peddi P; Pennell NA; Reynolds K; Rosen LR; Rosovsky R; Salazar M; Schmidt A; Shah SA; Shaya JA; Steinharter J; Stockerl-Goldstein KE; Subbiah S; Vinh DC; Wehbe FH; Weissmann LB; Wu JT; Wulff-Burchfield E; Xie Z; Yeh A; Yu PP; Zhou AY; Zubiri L; Mishra S; Lyman GH; Rini BI; Warner JL;
Lancet; 2020 Jun; 395(10241):1907-1918. PubMed ID: 32473681
[TBL] [Abstract][Full Text] [Related]
5. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients.
Basse C; Diakite S; Servois V; Frelaut M; Noret A; Bellesoeur A; Moreau P; Massiani MA; Bouyer AS; Vuagnat P; Malak S; Bidard FC; Vanjak D; Kriegel I; Burnod A; Bilger G; Ramtohul T; Dhonneur G; Bouleuc C; Cassoux N; ; Paoletti X; Bozec L; Cottu P
JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa090. PubMed ID: 33604509
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
Martin B; DeWitt PE; Russell S; Anand A; Bradwell KR; Bremer C; Gabriel D; Girvin AT; Hajagos JG; McMurry JA; Neumann AJ; Pfaff ER; Walden A; Wooldridge JT; Yoo YJ; Saltz J; Gersing KR; Chute CG; Haendel MA; Moffitt R; Bennett TD
JAMA Netw Open; 2022 Feb; 5(2):e2143151. PubMed ID: 35133437
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
10. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
11. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.
Brar G; Pinheiro LC; Shusterman M; Swed B; Reshetnyak E; Soroka O; Chen F; Yamshon S; Vaughn J; Martin P; Paul D; Hidalgo M; Shah MA
J Clin Oncol; 2020 Nov; 38(33):3914-3924. PubMed ID: 32986528
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
Lee RJ; Wysocki O; Bhogal T; Shotton R; Tivey A; Angelakas A; Aung T; Banfill K; Baxter M; Boyce H; Brearton G; Copson E; Dickens E; Eastlake L; Gomes F; Hague C; Harrison M; Horsley L; Huddar P; Hudson Z; Khan S; Khan UT; Maynard A; McKenzie H; Palmer D; Robinson T; Rowe M; Thomas A; Tweedy J; Sheehan R; Stockdale A; Weaver J; Williams S; Wilson C; Zhou C; Dive C; Cooksley T; Palmieri C; Freitas A; Armstrong AC
ESMO Open; 2021 Feb; 6(1):100005. PubMed ID: 33399072
[TBL] [Abstract][Full Text] [Related]
16. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
17. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
[TBL] [Abstract][Full Text] [Related]
19. Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country.
Hammad M; Shalaby L; Sidhom I; Sherief N; Abdo I; Soliman S; Madeny Y; Hassan R; Elmeniawy S; Khamis N; Zaki I; Mansour T; El-Ansary MG; Al-Halfawy A; Abouelnaga S; Elhaddad A
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e853-e864. PubMed ID: 34420893
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
